Range Impact Reports Q2 2025 Financial Results: Revenue Down 17% YoY
PorAinvest
jueves, 14 de agosto de 2025, 5:28 pm ET1 min de lectura
• Range Impact reports Q2 2025 financial results • CEO Michael Cavanaugh highlights quarterly results • Focus on digital data not mentioned in the article
WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) has announced its interim consolidated financial results for the quarter ended June 30, 2025, showcasing impressive growth across key financial metrics. The company achieved record quarterly revenues of $356.7 million in Q2-2025, an increase of 57% compared to Q2-2024. This growth was primarily driven by organic expansion and acquisitions, with a notable contribution of $40.5 million from the inclusion of HEALWELL AI [1].Excluding the impact of Circle Medical’s deferred revenue adjustments, known as "CM Deferrals," revenue would have been $347.0 million, representing a 53% year-over-year growth. Adjusted EBITDA(1) for the quarter was $49.7 million, an increase of 231% compared to Q2-2024, with a significant contribution from HEALWELL AI. Adjusted Net Income(1) reached $25.8 million, or $0.10 per share, marking a 532% increase from the previous year.
The company's Canadian Patient Services revenue grew to $114.5 million in Q2-2025, an increase of 49% compared to Q2-2024, driven by both organic growth and acquisitions. Consolidated gross margins increased by 423 basis points to 44.5%, primarily due to the addition of higher-margin HEALWELL revenue.
CEO Hamed Shahbazi highlighted the quarter's performance, noting that it reflects a significant milestone in the company's history. He emphasized the importance of technology and innovation in delivering better healthcare outcomes and the growing relevance of WELL's ecosystem in the healthcare sector.
The company also reaffirmed its annual guidance for revenue between $1.40 billion to $1.45 billion and Adjusted EBITDA between $190 million to $210 million, excluding CM Deferrals, the guidance was revised to $1.35 billion to $1.40 billion and $140 million to $160 million, respectively. The improved guidance reflects the company's strong performance and confidence in its future prospects.
WELL Health Technologies remains focused on driving sustainable, profitable growth through strategic acquisitions and investments in technology and innovation. The company's strong balance sheet and increasing cash generation position it well for long-term growth and value creation for shareholders.
References:
[1] https://finance.yahoo.com/news/well-health-reports-record-revenue-110100432.html
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema



Comentarios
Aún no hay comentarios